Department of Otorhinolaryngology-Head and Neck Surgery, Okmeydani Training and Research Hospital, University of Health Science, Istanbul, Turkey.
Department of Biochemistry, Okmeydani Training and Research Hospital, University of Health Science, Istanbul, Turkey.
Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3383-3388. doi: 10.1007/s00405-019-05640-0. Epub 2019 Sep 20.
To investigate the association of allergic rhinitis (AR) severity with neutrophil-lymphocyte and platelet-lymphocyte ratios in adult patients.
The study design was prospective observational study and the study included 209 AR patients and 243 healthy individuals. The patient group comprised 38.2% males with a mean age of 31.8 years. All patients who were diagnosed with persistent AR were included. The healthy control group comprised 52.7% males with a mean age of 32.3 years. The blood examination results of patients and healthy individuals were compared in terms of neutrophil-lymphocyte and platelet-lymphocyte ratios. The values were further compared within the patient group, according to AR severity.
The neutrophil-lymphocyte ratio was 1.70 ± 0.65 in the healthy group and 2.02 ± 1.24 in the patient group. The platelet-lymphocyte ratio result was 100.85 ± 25.33 in the healthy group and 120.67 ± 40.59 in the patient group. When we compared the neutrophil-lymphocyte and platelet-lymphocyte ratios between the groups, we found statistically significant differences in both ratios (p = 0.003, p = 0.000, respectively). Both the neutrophil-lymphocyte and the platelet-lymphocyte ratios were higher in patients with moderate-severe AR.
Both neutrophil-lymphocyte and platelet-lymphocyte ratios are useful markers for diagnosis of persistent AR. Specialists may benefit from these markers to assess the severity of the disease at the beginning of the diagnostic process.
探讨成人变应性鼻炎(AR)严重程度与中性粒细胞-淋巴细胞和血小板-淋巴细胞比值的关系。
研究设计为前瞻性观察性研究,共纳入 209 例 AR 患者和 243 名健康对照者。患者组中男性占 38.2%,平均年龄为 31.8 岁,均为持续性 AR 患者。健康对照组中男性占 52.7%,平均年龄为 32.3 岁。比较患者组和健康对照组的中性粒细胞-淋巴细胞和血小板-淋巴细胞比值的血液检查结果,并根据 AR 严重程度对患者组内的这些比值进行进一步比较。
健康组中性粒细胞-淋巴细胞比值为 1.70±0.65,患者组为 2.02±1.24;健康组血小板-淋巴细胞比值为 100.85±25.33,患者组为 120.67±40.59。组间比较时,两组的中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值均存在统计学差异(p=0.003,p=0.000)。中重度 AR 患者的中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值均较高。
中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值均有助于持续性 AR 的诊断。在诊断过程的初始阶段,这些标志物可能有助于评估疾病的严重程度。